Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE starting June 12 2026

Cancer-causing parasite 'could save lives'

A carcinogenic liver parasite is being touted as a potentially "revolutionary" treatment that could save the lives of diabetics with chronic wounds.

Carcinogenic liver parasites might sound like a patient's nightmare, but Queensland researchers believe the proteins in them could "supercharge" healing of chronic wounds.

They hope their "revolutionary" discovery will end up saving the lives and livelihoods of diabetics.

"Every day 12 Australian diabetics have a limb amputated because of a chronic wound. Globally, it's one every 30 seconds," James Cook University researched Dr Michael Smout said.

A tendency for stubborn inflammation and poor circulation inhibit diabetics' bodies from closing wounds and battling infection, and there are currently no medicinal treatments available to remedy chronic wounds in Australia.

"If a diabetic gets an amputation, they have a five year survival rate of only 50 per cent, so it's absolutely critical these wounds are healed before they get to that point," Dr Smout told the AAP on Monday.

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Dr Smout said there is one drug available internationally, but it has limited success - only a one-in-two chance of improving healing by 22 per cent.

He hopes the drug his team is working on can do much better - their testing on mice revealed a 43 per cent improvement in wound healing.

The research team 'ironically' discovered the healing powers of the Southeast Asian liver fluke by trying to kill it with a vaccine.

The fluke, most prevalent in Thailand, is usually contracted from undercooked or raw fish and infests the liver often leading to bile duct cancer.

They decided to steal the worm's secret trick and re-engineer granulin protein from the parasite into smaller, simpler molecules to be utilised in a topical cream.

Researchers have only tested the cream on mice so far, but hope to securing funding to conduct a small scale human trial, and then mass produce the life-saving drug.


2 min read

Published

Source: AAP



Share this with family and friends


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world